ask="3.74"
ask_size="300"
average_daily_volume="36576"
bid="3.26"
bid_size="400"
book_value="0.00"
change="+0.18"
change_from_200_day_moving_average="-1.38"
change_from_50_day_moving_average="-0.31"
change_from_52_week_high="-10.04"
change_From_52_week_low="0.61"
change_in_percent="+5.82%"
close="3.26"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-11.27"
ebitda="0.00"
eps_estimate_current_year="-5.06"
eps_estimate_next_quarter="-0.84"
eps_estimate_next_year="-3.18"
ex_dividend_date="N/A"
float_shares="N/A"
high="3.36"
high_52_weeks="13.30"
last_trade_date="1/4/2017"
last_trade_price="3.26"
last_trade_size="289"
last_trade_time="4:00pm"
low="3.12"
low_52_weeks="2.65"
market_capitalization="N/A"
moving_average_200_day="4.64"
moving_average_50_day="3.57"
name="Caladrius Biosciences
Inc."
notes="N/A"
one_year_target_price="11.17"
open="3.12"
pe_ratio="N/A"
peg_ratio="-0.01"
percent_change_from_200_day_moving_average="-29.68%"
percent_change_from_50_day_moving_average="-8.64%"
percent_change_from_52_week_high="-75.49%"
percent_change_from_52_week_low="+23.02%"
previous_close="3.08"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NCM"
symbol="CLBS"
volume="44776"
weeks_range_52="2.65 - 13.30"
